Assess safety and tolerability profile of lumiracoxib in comparison to baseline [clinicaltrials_resource:6c71c432d7682314b9543726fce1f6ee]

Assess safety and tolerability profile of lumiracoxib in comparison to baseline [clinicaltrials_resource:6c71c432d7682314b9543726fce1f6ee]

clinicaltrials resource [clinicaltrials_vocabulary:Resource]
Secondary outcome [clinicaltrials_vocabulary:secondary-outcome]
http://bio2rdf.org/clinicaltrials_resource:6c71c432d7682314b9543726fce1f6ee
6 Week Open-label Trial With Lumiracoxib 200mg o.d. in Primary Knee Osteoarthritis or Rheumatoid Arthritis [clinicaltrials:NCT00170872]
clinicaltrials_vocabulary:secondary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:secondary-outcome]

Assess safety and tolerability profile of lumiracoxib in comparison to baseline [clinicaltrials_resource:6c71c432d7682314b9543726fce1f6ee]

clinicaltrials resource [clinicaltrials_vocabulary:Resource]
Secondary outcome [clinicaltrials_vocabulary:secondary-outcome]
http://bio2rdf.org/clinicaltrials_resource:6c71c432d7682314b9543726fce1f6ee
Bio2RDF identifier
6c71c432d7682314b9543726fce1f6ee
Bio2RDF namespace
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:6c71c432d7682314b9543726fce1f6ee
measure [clinicaltrials_vocabulary:measure]
Assess safety and tolerability profile of lumiracoxib in comparison to baseline
identifier
clinicaltrials_resource:6c71c432d7682314b9543726fce1f6ee
title
Assess safety and tolerability profile of lumiracoxib in comparison to baseline
@en
inDataset
type
label
Assess safety and tolerability ...... 1c432d7682314b9543726fce1f6ee]
@en